Health & Biotech
Health & Biotech
PharmAust gets ethics committee green light for open-label MND extension study
Health & Biotech
Neurotech gets green light to start phase I/II cerebral palsy trial
Health & Biotech
Bioxyne’s Q2 FY24 revenue surpasses $2.5m on Aussie medicinal cannabis growth
Health & Biotech
ASX Health Stocks: Starpharma says Viraleze reduces viral load in nose, effective in Covid-19
Health & Biotech
FDA offers PharmAust clear guidance for orphan drug designation approval
Health & Biotech
Enivo pilot clinical study shows promise for reducing mastectomy complications
Health & Biotech
ASX Health Stocks: Memphasys tumbles almost 30pc after cow pregnancy trial disappoints
Health & Biotech
Neurotech moves to show economic advantage of autism treatment as Phase II/III trial results due soon
Health & Biotech
Weed Week: Medicinal cannabis will be here no matter what; and recent ASX pot winners
Health & Biotech
ASX Health Stocks: CBL to advance DROVE wheelchair in US; Nanosonics dives 32pc after H1 update
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
Health & Biotech
AdAlta advancing partnering programs as AD-214 participants receive final dose
Health & Biotech
Bioxyne subsidiary unveils platform for transparent pricing in Australia’s B2B medical cannabis market
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall as Morgans upgrades Sigma on proposed Chemist Warehouse merger
Health & Biotech
ASX Health Stocks: Mesoblast rockets 20pc after being granted Rare Pediatric Disease Designation by FDA
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.